Siemens, Mayo Clinic Expand Collaboration for Advanced Medical Tech

Partnership aims to enhance patient care for neurodegenerative disease, prostate cancer, and metastatic liver tumors.

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Siemens Healthineers and Mayo Clinic have signed an agreement to expand their strategic collaboration, focusing on developing and bringing to clinical use new imaging and interventional technologies to improve care for people with neurodegenerative diseases, prostate cancer, and metastatic liver tumors.

Why it matters

The partnership aims to make care more precise, less invasive, and more responsive to each patient's needs by leveraging advanced imaging, artificial intelligence, and innovative treatment approaches to enable earlier diagnoses, more personalized treatment plans, and better outcomes for patients.

The details

Initial areas for collaboration include developing AI-enabled MRI protocols for improved diagnostic accuracy and patient monitoring of neurodegenerative diseases, applying digital twin technologies to reimagine the surgical care pathway, investigating the role of AI in minimizing biopsies and integrating minimally invasive, advanced imaging into diagnostic and therapeutic procedures for prostate cancer, and creating specialized spaces to use the latest image-guided technologies for the precise detection and treatment of liver metastases.

  • The expanded collaboration agreement was signed in February 2026.

The players

Siemens Healthineers

A leading medical technology company that develops and manufactures diagnostic and therapeutic imaging equipment, laboratory diagnostics, and molecular medicine solutions.

Mayo Clinic

A nonprofit organization committed to clinical practice, education, and research, providing comprehensive and integrated care to patients from all 50 U.S. states and nearly 140 countries.

Eric Williamson, M.D.

Professor and chair of Diagnostic Radiology at Mayo Clinic.

John Kowal

President and head of the Americas at Siemens Healthineers.

Got photos? Submit your photos here. ›

What they’re saying

“Our goal is to make care more precise, less invasive and more responsive to each patient's needs. By expanding our collaboration, we can bring advanced imaging, artificial intelligence and innovative treatment approaches directly into everyday clinical care, potentially helping patients receive earlier diagnoses, more personalized treatment plans and better outcomes.”

— Eric Williamson, M.D., Professor and Chair, Diagnostic Radiology, Mayo Clinic

“Improving the diagnosis and treatment of neurodegenerative disease and cancer is core to our purpose as a company. Our collaboration with Mayo Clinic creates significant opportunities to help extend the quantity and quality of patients' lives.”

— John Kowal, President and Head of the Americas, Siemens Healthineers

What’s next

The two organizations plan to continue expanding their collaboration to develop and bring to clinical use new imaging and interventional technologies that can improve patient care and outcomes.

The takeaway

This expanded partnership between a leading medical technology company and a renowned healthcare provider demonstrates the potential for innovative collaborations to drive advancements in precision medicine and transform the patient experience through the integration of cutting-edge imaging, AI, and minimally invasive treatment approaches.